SCHEMBL8121503

SCHEMBL8121503

Cc1ccc(-c2cc(-c3ccc(Cl)cc3)nn2-c2ccc(S(N)(=O)=O)cc2)cc1

nearest known ligand 0.83

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ PTGS2 P35354 14/20 0.83
▸ CYP2C9 P11712 2/20 0.80
▸ PTGS1 P23219 5/20 0.78
▸ CHRNA7 P36544 2/20 0.65
▸ PDPK1 O15530 3/20 0.64
▸ CA1 P00915 2/20 0.64
▸ CA2 P00918 2/20 0.64
▸ CA9 Q16790 2/20 0.64
▸ PTGES O14684 1/20 0.64
▸ HDAC3 O15379 1/20 0.64
▸ CA12 O43570 1/20 0.64
▸ PDE5A O76074 1/20 0.64
▸ ABCB11 O95342 1/20 0.64
▸ MT-CO2 P00403 1/20 0.64
▸ LMNA P02545 1/20 0.64
▸ CA3 P07451 1/20 0.64
▸ CYP3A4 P08684 1/20 0.64
▸ ALOX5 P09917 1/20 0.64
▸ ADORA3 P0DMS8 1/20 0.64
▸ CYP2D6 P10635 1/20 0.64

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL212983 1.00 PTGS2 (0.83) PTGS2CYP2C9PTGS1CHRNA7PDPK1
SCHEMBL212919 0.94 CYP2C9 (0.90) PTGS2CYP2C9PTGS1PDPK1CA1
SCHEMBL5698697 0.94 PTGS2 (0.88) PTGS2CYP2C9PTGS1CHRNA7PDPK1
SCHEMBL6452272 0.93 PTGS2 (0.92) PTGS2CYP2C9PTGS1CHRNA7CA1
SCHEMBL8126311 0.92 PTGS2 (0.77) PTGS2CYP2C9PTGS1CHRNA7PDPK1
SCHEMBL8112204 0.89 PTGS2 (0.80) PTGS2CYP2C9PTGS1CHRNA7PDPK1
SCHEMBL8112778 0.89 PTGS2 (0.80) PTGS2CYP2C9PTGS1CHRNA7PDPK1
SCHEMBL8420798 0.89 PTGS2 (0.80) PTGS2CYP2C9PTGS1ALOX5
SCHEMBL212707 0.89 PTGS2 (0.80) PTGS2CYP2C9PTGS1CHRNA7PDPK1
SCHEMBL8424052 0.89 PTGS2 (0.80) PTGS2CYP2C9PTGS1ALOX5

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0731796-B1 1,3,5-TRISUBSTITUTED PYRAZOLE COMPOUNDS FOR TREATMENT OF INFLAMMATION SEARLE & CO (US) 2000-08-02 — — EP claimed
EP-0731796-A1 1,3,5-TRISUBSTITUTED PYRAZOLE COMPOUNDS FOR TREATMENT OF INFLAMMATION G.D. SEARLE & CO. (US) 1996-09-18 — — EP claimed
WO-1995015318-A1 1,3,5-TRISUBSTITUTED PYRAZOLE COMPOUNDS FOR TREATMENT OF INFLAMMATION G.D. SEARLE & CO. (US) 1995-06-08 — — WO claimed
EP-0731796-B1 1,3,5-TRISUBSTITUTED PYRAZOLE COMPOUNDS FOR TREATMENT OF INFLAMMATION SEARLE & CO (US) 2000-08-02 — — EP disclosed
EP-0731796-A1 1,3,5-TRISUBSTITUTED PYRAZOLE COMPOUNDS FOR TREATMENT OF INFLAMMATION G.D. SEARLE & CO. (US) 1996-09-18 — — EP disclosed
US-5434178-A 1,3,5 trisubstituted pyrazole compounds for treatment of inflammation G.D. SEARLE & CO. (US) 1995-07-18 — — US disclosed
WO-1995015318-A1 1,3,5-TRISUBSTITUTED PYRAZOLE COMPOUNDS FOR TREATMENT OF INFLAMMATION G.D. SEARLE & CO. (US) 1995-06-08 — — WO disclosed
Send feedback